🇺🇸 FDA

Intelligence Platform

Patents

Browse 3,720 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7777019

Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776883

Quinolin-4-ones as inhibitors of retroviral integrase for the treatment of HIV, AIDS and A

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7776521

Coronavirus isolated from humans

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7771715

Recombinant vector expressing multiple costimulatory molecules and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7771956

Method for detecting the presence of a phospholipid

The United States of America—Department of Veterans Affairs · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7771729

Methods of potentiating HIV-1-specific CD8+ immune responses involving the concomitant adm

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 10 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 05 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7767645

SH2 domain binding inhibitors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763719

Variants of humanized anti-carcinoma MAb CC49

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763451

Methods for preparing Bacillus anthracis protective antigen for use in vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7763586

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7758876

Method of preventing infections from bioterrorism agents with immunostimulatory CpG oligon

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759330

21-substituted progesterone derivatives as new antiprogestational agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7759106

Construction of live attenuated Shigella vaccine strains that express CFA/I antigens (CfaB

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7758855

DNA promoters and anthrax vaccines

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754420

Methods of using cyanovirins to inhibit viral infection

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754676

Defensin-antigen fusion proteins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754461

Large-scale production of human serum butyrylcholinesterase as a bioscavenger

The United States of America as represented by the Secretary of the Army · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7754227

Method of immunizing humans against Salmonella typhi using a Vi-rEPA conjugate vaccine

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749967

Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749984

Computer-based model for identification and characterization of non-competitive inhibitors

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7749719

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745388

Peptides for activation and inhibition of δPKC

The United States of America as represented by NIH Division of Extramural Inventions and Technology Resources (DEITR) · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745212

Melanoma antigens and their use in diagnostic and therapeutic methods

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7745144

Peptides and their utility in modulation of behavior of cells expressing α3β1 integrins

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted